Beitrag schreiben
Ansicht
-
Umgekehrte Sortierung (neuste zuerst)
-
Die letzten 30 Beiträge
-
500 Beiträge pro Seite
[ Seite: 1, 2, 3 … 44, 45, 46, neuster Beitrag ]
schrieb am 31.01.12 10:04:32
@schürger,
100% zustimmung habe PM schon seit 1992 permanent im
depot.


mo,pm und kraft foods gehören in jedes depot.
schrieb am 31.01.12 10:10:11
Antwort auf Beitrag Nr.: 42.672.312
von pedestrian am 31.01.12 10:04:32phillip
morris cr kaufe ich auch noch.warte hier auf einen kleinen
dämpfer.
so bei 350 euro steige ich ein.
habe damals anstatt pm cr,pm gekauft.
schrieb am 31.01.12 15:51:10
Hallo!
Ich hab die PM-CR rausgeschmissen. Grund ist die unterschiedliche
Versteuerung in Ösiland. Bei der tschechischen PM steig ich mit 25%
KEST aus, bei der PM Mutter mit 10%. Man glaubt das kaum, aber so
ist es. Daher bei PM kräftig nachgelegt.
der
Dividendenabstauber
schrieb am 01.02.12 21:03:04
Antwort auf Beitrag Nr.: 42.674.455
von Dividendenabstauber am 31.01.12
15:51:10@dividendenabstauber,
am 21.12.2011 hat der fiskus eine schlappe erlitten.im ausland
gezahlte quellensteuer muss angerechnet werden.die letzten 5 jahre
kannst du geltend machen.
http://www.capital.de/steuern-recht/:Quellensteuer--Schlappe-fuer-den-Fiskus/100043787.html?p=2
schrieb am 15.02.12 13:26:12
Altria Reports 2011 Fourth-Quarter and Full-Year Results and
Delivers 2011 Full-Year Adjusted EPS Growth of 7.9%
Altria’s 2011 reported diluted earnings per share (EPS) down 6.8%
to $0.41 for the fourth quarter and down 12.3% to $1.64 for the
full year primarily due to impact of special items, including a
2011 second-quarter charge related to certain leveraged lease
transactions, 2011 fourth-quarter restructuring charges related to
the cost reduction program announced in October 2011, and charges
related to tobacco and health judgments
Altria’s 2011 adjusted diluted EPS, which excludes the impact of
special items, including charges related to tobacco and health
judgments, up 13.6% to $0.50 for the fourth quarter and up 7.9% to
$2.05 for the full year
Altria forecasts that 2012 full-year reported diluted EPS will be
in the range of $2.14 to $2.20, and 2012 full-year adjusted diluted
EPS will be in the range of $2.17 to $2.23, representing a growth
rate of 6% to 9% from an adjusted base of $2.05 in 2011
Altria Client Services has entered into an agreement with Okono
A/S, an affiliate of Fertin Pharma A/S, to develop innovative,
non-combustible nicotine-containing products for adult tobacco
consumers
Altria’s Chairman and Chief Executive Officer, Michael E.
Szymanczyk, 63, has decided to retire; Altria’s Board of Directors
(Board) elects Martin J. Barrington, 58, to serve as Altria’s
Chairman and Chief Executive Officer, and David R. Beran, 57, to
serve as Altria’s President and Chief Operating Officer, effective
May 17, 2012; Mr. Barrington joins Altria’s Board effective
immediately
RICHMOND, Va.--(BUSINESS WIRE)--Jan. 27, 2012-- Altria Group, Inc.
(Altria) (NYSE: MO) today announced its 2011 fourth-quarter and
full-year results, and provided its 2012 full-year guidance for
reported and adjusted diluted EPS.
“Altria delivered strong returns for its shareholders in 2011 in a
challenging business environment while taking steps to continue
creating shareholder value into the future,” said Michael E.
Szymanczyk, Chairman and Chief Executive Officer (CEO) of Altria.
“Altria grew its redefined adjusted diluted EPS by 7.9% behind the
strength of our tobacco and wine businesses.”
“Altria outperformed the S&P 500 Index for the twelfth
consecutive year and delivered total shareholder return of 26.9%,”
said Mr. Szymanczyk. “In 2011, Altria created shareholder value by
increasing its dividend by 7.9%, repurchasing $1.3 billion of its
shares, completing a $1.5 billion 2007 to 2011 cost reduction
program and announcing a new cost reduction program for its tobacco
and services companies in October.”
“Altria continues to focus on developing lower risk products that
appeal to adult tobacco consumers,” said Mr. Szymanczyk. “To
support this goal, I am pleased to announce that Altria Client
Services has entered into an agreement with Okono A/S, an affiliate
of Fertin Pharma A/S, to develop innovative, non-combustible
nicotine-containing products for adult tobacco consumers. This new
product initiative combines the expertise of the Altria family of
companies with Okono and its affiliates' product development and
manufacturing capabilities.”
Chairman and CEO Transition
Altria also announced today that Michael E. Szymanczyk, 63, has
decided to retire after 23 years of distinguished service to the
company, including four years as Chairman and CEO of Altria and 12
years as President and CEO of Philip Morris USA (PM USA). The Board
has elected Martin J. Barrington, 58, to serve as Altria’s Chairman
and CEO, effective upon Mr. Szymanczyk’s retirement following the
Annual Meeting of Shareholders on May 17, 2012. The Board also has
elected Mr. Barrington to Altria’s Board, effective
immediately.
Additionally, the Board elected David R. Beran, 57, to serve as
Altria’s President and Chief Operating Officer, effective May 17,
2012, and approved a consulting agreement with Mr. Szymanczyk for
an initial period ending January 31, 2014.
“It has been an extraordinary experience to lead the reshaping of
Altria following the completion of the Kraft and Philip Morris
International spin-offs,” said Mr. Szymanczyk. “I believe the
company is well positioned to continue to prosper. As I near
retirement, now is the time to transition leadership to people of
an age to guide the company through its next phase of growth.”
“We are grateful for Mike Szymanczyk’s tremendous contributions to
the company and its shareholders and are particularly pleased that
he is willing to continue to share his expertise and insights
through a consulting arrangement,” said Thomas Farrell, the
Presiding Director. “Our choice of Mr. Barrington at this time as
the next Chairman and CEO is the culmination of our systematic
succession planning process. We are very enthusiastic about his
proven ability to provide the vision and leadership necessary for
this company to continue both to build its strong tobacco and wine
core businesses and to develop new revenue opportunities in an era
of expanding FDA regulation and evolving adult tobacco consumer
preferences.”
“It is a real honor to follow Mike Szymanczyk in this role,” said
Mr. Barrington. “He has led the company with exceptional skill,
commitment and passion through Altria’s reshaping, including the
expansion and diversification of Altria’s tobacco platform into the
cigar and smokeless tobacco businesses. We are very fortunate to
have someone with Dave Beran’s capabilities and experience to serve
as President and Chief Operating Officer and I look forward to
working with Dave and Altria’s terrific management team to continue
to achieve superior shareholder returns.”
Mr. Barrington has held various roles in the Altria family of
companies since 1993, including, most recently, as Vice Chairman.
He has also served as General Counsel of both PM USA and Philip
Morris International Inc. (PMI). In these and other roles he has
participated in the work of virtually every business function of
the Altria family of companies, through direct business
responsibility for regulatory and external affairs, research and
development, human resources and compliance, as well as working
closely with marketing, sales, strategy and business development
and operations. He has a B.A. from the College of Saint Rose and a
J.D. from Albany Law School.
Mr. Beran joined the Altria family of companies in 1976 and has
held leadership positions in finance, operations, planning and
information, market research and marketing, most recently as Vice
Chairman responsible for business operations. He has a B.S. from
the University of Virginia and an M.B.A. from the University of
Richmond.
schrieb am 26.04.12 21:01:36
profitiert von höheren Zigarettenpreisen
Kategorie: US-Markt News | Uhrzeit: 20:42
New York (BoerseGo.de) – Der Tabak-Gigant Altria Group hat im
ersten Quartal beim Umsatz und Gewinn eine Punktlandung auf die
Analystenschätzungen gesetzt. Aufgrund höherer Zigarettenpreise bei
der Kernmarke Marlboro und Einsparungen im Konzern konnte der
Konzerngewinn leicht gesteigert werden.
Konzernchef Michael Szymanczyk geht davon aus, dass der Konzern im
laufenden Geschäftsjahr weitere Preisanhebungen durchsetzen kann,
weshalb die Jahresguidance bestätigt wurde.
Altria berichtete ein Gewinnwachstum pro Aktie um 6,7 Prozent auf
0,48 US-Dollar. Bereinigt um Einmaleffekte stellte sich wie von den
Analysten erwartet ein Plus von 11,4 Prozent auf 0,49 US-Dollar
ein. Bereinigt lag der Gewinn damit bei 973 Millionen US-Dollar.
Der Umsatz lag mit 3,99 Milliarden US-Dollar auf Augenhöhe mit den
Erwartungen von 4,01 Milliarden US-Dollar.
Altria bekräftigte die Prognose für das Gesamtjahr. Der Gewinn je
Aktie soll im Bereich von 2,14 bis 2,20 US-Dollar liegen. Bereinigt
um Einmaleffekte wird ein Ergebnis je Aktie im Bereich von 2,17 bis
2,23 US-Dollar angestrebt, was einem Wachstum von 6 bis 9 Prozent
gegenüber dem Jahr 2011 entsprechen würde.